Acadia Makes New Appointment
This article was originally published in Scrip
Acadia Pharmaceuticals Inc. has appointed Srdjan (Serge) Stankovic executive vice president, head of research and development. Most recently Stankovic was senior vice president of clinical development and medical affairs at Alkermes Plc. and prior to this he was senior vice president and head of global clinical development for Teva Pharmaceuticals. Stankovic also held executive positions in research and development at Forest Laboratories, Inc., Neurogen Corporation, Johnson and Johnson and UCB.